More Virtual Posters
Robert Spiera, Sebastian Unizony, Kenneth J. Warrington, Jennifer Sloane Lazar, Angeliki Glannelou, Michael C Nivens, Bolanie Akinlade, Wanling Wong, Yong Lin, Frank Buttgereit, Valerie Devauchelle-Pensec, Andrea Rubbert-Roth, Bhaskar Dasgupta
Abstract or description:The poster reports post-hoc results from the SAPHYR study on the resolution of PMR signs and symptoms regardless of glucocorticoid (GC) use and GC-free resolution of PMR signs and symptoms over time. GC-free resolution of PMR signs and symptoms was maintained from week 16 to week 52 in majority of patients treated with sarilumab 200mg Q2W + 14week GC.
Robert Spiera, Sebastian Unizony, Kenneth J. Warrington, Jennifer Sloane Lazar, Angeliki Glannelou, Michael C Nivens, Bolanie Akinlade, Wanling Wong, Yong Lin, Frank Buttgereit, Valerie Devauchelle-Pensec, Andrea Rubbert-Roth, Bhaskar Dasgupta
Abstract or description:The poster reports post-hoc results from the SAPHYR study on the resolution of PMR signs and symptoms regardless of glucocorticoid (GC) use and GC-free resolution of PMR signs and symptoms over time. GC-free resolution of PMR signs and symptoms was maintained from week 16 to week 52 in majority of patients treated with sarilumab 200mg Q2W + 14week GC.
